Mesoblast (MESO) Times Interest Earned (2014 - 2023)
Mesoblast (MESO) posted Times Interest Earned of -$3.93 for Q2 2023, down 1970.58% sequentially from -$0.19 in Q1 2023, and down 86793.15% YoY from N/an in Q2 2022.
Mesoblast (MESO) Times Interest Earned (2014 - 2023) Analysis & Trends
Mesoblast has reported Times Interest Earned for 10 years, with the latest figure at -$3.93 in Q2 2023.
- Quarterly Times Interest Earned fell 86793.15% year-over-year to -$3.93 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$1.85 (up 22.31% YoY) and the FY2025 annual result came in at -$2.7, down 5.72% from the prior year.
- Times Interest Earned eased to -$3.93 in Q2 2023 per MESO's latest filing, from -$0.19 in the prior quarter.
- Over five years, Times Interest Earned peaked at $7.99 in Q2 2019 and troughed at -$7.64 in Q1 2019.
- A 5-year average of -$2.23 and a median of -$3.17 in 2020 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2023: Times Interest Earned soared 207.82% in 2021, then tumbled 86793.15% in 2023.
- Over 5 years, Times Interest Earned stood at -$6.46 in 2019, then grew by 16.13% to -$5.41 in 2020, then surged by 207.82% to $5.84 in 2021, then sank by 122.24% to -$1.3 in 2022, then sank by 202.89% to -$3.93 in 2023.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$3.93, -$0.19, and -$1.3 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -3.93 |
| Mar 31, 2023 | -0.19 |
| Dec 31, 2022 | -1.30 |
| Sep 30, 2022 | -2.72 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | 5.84 |
| Sep 30, 2021 | -4.48 |
| Jun 30, 2021 | -4.44 |
| Mar 31, 2021 | -5.74 |
| Dec 31, 2020 | -5.41 |
| Sep 30, 2020 | -5.44 |
| Jun 30, 2020 | -0.90 |
| Mar 31, 2020 | -3.61 |
| Dec 31, 2019 | -6.46 |
| Sep 30, 2019 | -1.07 |
| Jun 30, 2019 | 7.99 |
| Mar 31, 2019 | -7.64 |
| Dec 31, 2018 | 12.05 |
| Sep 30, 2018 | 8.62 |